Status: Not yet recruiting
Clinical Trials of IBI3035 in Healthy Subjects
This study is a Phase I clinical trial that uses positive glucose clamping technology to evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence of IBI3035 with insulin injection (Awiqli?) after a single administration in healthy male subjects
Participants needed: 144
Trial details
Phase: Phase 1Age: 18-45Biological sex: MaleType: InterventionalSponsor: Innovent Biologics (Suzhou) Co. Ltd.Updated: May 15, 2026Locations: 1
Eligibility criteria
Healthy male adult subjects aged 18 to 45 years (including 18 and 45 years, base... [+5]
Known or suspected to be allergic to the investigational drug in this study; [+13]